(Israel21c) Ruthie Blum - An Israeli breakthrough in the treatment of cancer developed by Tel Aviv University Professors Rimona Margalit and Dan Peer involves the use of "GAGomers," a new class of nanoparticles that specifically target tumors and blood cancers based on a biomarker expressed on malignant tissue. The bio-pharmaceutical company Quiet Therapeutics is working fast and furiously to make the innovation accessible and marketable to oncology patients and their doctors. CEO Dr. Ron Lahav explains: "When treated with nucleic acid-based substances (such as chemotherapeutic drugs) entrapped within the GAGomers, tumors induced in mice from human cancer cells were greatly reduced or eradicated altogether, and with no significant undesirable toxicity." The pioneering treatment not only promises to be more effective, but will involve far less suffering from the common side effects of chemotherapy, such as nausea and hair loss. Lahav received his PhD in environmental microbiology from Ben-Gurion University and a post-doctorate in molecular biology from Princeton.
2015-01-16 00:00:00Full ArticleBACK Visit the Daily Alert Archive